MetaCap

Arcturus Therapeutics Statistics

NASDAQ: ARCTHealth CareBiotechnology: Pharmaceutical PreparationsUSD

7.45-0.15 (-1.97%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Arcturus Therapeutics by the numbers

Arcturus Therapeutics has a market capitalization of $214.7 million based on 28.82M shares outstanding. With trailing EPS of $-3.10, Arcturus Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 36.4% below its 50-day average and 18.3% below its 200-day average.

Average daily trading volume is 851.45K shares, or about $6.3 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

ARCT valuation vs. peer median

ARCT compared with the median of 8 peer companies
MetricARCTPeer medianDifference
Market cap$214.73M$216.96M-1%
Avg. volume851.45K903.02K-6%

Peer median across 8 companies: PYXS, KROS, RCKT, IMRX, CYPH, VNDA, ENTA, FTH.

Valuation

Market cap
$214.73M
Price / sales (latest FY)
2.62
EPS (TTM)
$-3.10

Price and trading

Previous close
7.60
Open
7.38
Day range
7.31 – 7.73
52-week range
5.50 – 17.96
52-week change
+19.01%
Beta
—
Volume
601.93K

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
214.73M
Forward Pe
-2.18
Eps
-3.10
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
17.96
Week52 Low
5.50
Avg Volume
851.45K
Shares Outstanding
28.82M
Ma50
11.72
Ma200
9.12
Earnings Date
Nov 5, 2026
Pct From52w High
-58.52%
Pct From52w Low
35.45%

Related